Omeprazole and sodium bicarbonate
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole and Sodium Bicarbonate: Efficacy and Stability in Treating Acid-Related Disorders
Introduction to Omeprazole and Sodium Bicarbonate Combination
Omeprazole, a proton pump inhibitor (PPI), is widely used to treat acid-related disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. Sodium bicarbonate is often combined with omeprazole to enhance its efficacy by increasing gastric pH, which protects omeprazole from acid degradation and allows for faster absorption.
Acid Inhibitory Effects of Omeprazole and Sodium Bicarbonate
Comparative Studies on Acid Inhibition
A study comparing the acid inhibitory effects of a combination of immediate-release omeprazole (40 mg) and sodium bicarbonate (1100 mg) (CDFR0209) with delayed-release omeprazole (40 mg) found that both formulations were equally effective in decreasing integrated gastric acidity at steady state . This suggests that the combination of omeprazole and sodium bicarbonate can be as effective as traditional delayed-release formulations in managing gastric acidity.
Efficacy in Treating Helicobacter pylori Infection
In the context of Helicobacter pylori infection, a study compared the efficacy of omeprazole-amoxicillin therapy with ranitidine/sodium bicarbonate-amoxicillin therapy. The results indicated poor cure rates for both treatments, with omeprazole-amoxicillin achieving a 46% cure rate and ranitidine/sodium bicarbonate-amoxicillin achieving a 39% cure rate . This highlights the need for more effective treatment regimens for H. pylori infection.
Efficacy in Gastroesophageal Reflux Disease (GERD)
Systematic Review Findings
A systematic review assessing the efficacy of omeprazole/sodium bicarbonate in GERD patients found no significant difference between the combination therapy and omeprazole alone. However, there was a trend towards a more sustained response and greater proportion of patients experiencing total relief within 30 minutes with the combination therapy 34. This suggests that while the overall efficacy may be similar, the combination may offer faster symptom relief for some patients.
Stability of Omeprazole and Sodium Bicarbonate Formulations
Stability in Various Conditions
The stability of omeprazole in combination with sodium bicarbonate has been extensively studied. Omeprazole-sodium bicarbonate suspensions were found to be stable for up to 14 days at room temperature and up to 30 days when refrigerated or frozen . Additionally, partial doses of the suspension remained stable following exposure to simulated gastric fluid, making it feasible for pediatric use through nasogastric feeding tubes .
Pediatric Use and Administration
In pediatric patients, especially those undergoing liver or intestinal transplantation, omeprazole suspended in sodium bicarbonate was effective in maintaining gastric pH and preventing stress-related gastric bleeding. A dosage of 0.5 mg/kg every 12 hours was generally sufficient, though some patients required more frequent dosing to ensure continuous acid suppression .
Conclusion
The combination of omeprazole and sodium bicarbonate offers a viable alternative to traditional delayed-release omeprazole formulations, providing similar efficacy in reducing gastric acidity and potentially faster symptom relief in GERD patients. Its stability under various conditions and suitability for pediatric administration further enhance its clinical utility. However, its effectiveness in treating H. pylori infection remains limited, indicating the need for improved therapeutic strategies in this area.
Sources and full results
Most relevant research papers on this topic
Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin.
Both omeprazole and high dose of ranitidine plus sodium bicarbonate plus amoxicillin therapies failed to effectively treat Helicobacter pylori infection.
Efficacy of omeprazole/sodium bicarbonate treatment in gastroesophageal reflux disease: a systematic review.
Omeprazole/sodium bicarbonate therapy is not more effective than omeprazole in treating gastroesophageal reflux disease, but it may provide more sustained relief and relief by 30 minutes.
Bioequivalence Study of Two Oral-Capsule Formulations of Omeprazole 20 mg in Combination with Sodium Bicarbonate in Healthy Mexican Adult Volunteers
The immediate-release formulation of omeprazole 20 mg in combination with sodium bicarbonate is bioequivalent to the delayed-release formulation in treating gastritis, reflux, heartburn, and emptiness caused by excessive acid production in healthy Mexican adult volunteers.
DOI
Stability of omeprazole in an extemporaneously prepared oral liquid.
Omeprazole 2 mg/mL in an oral liquid compounded from capsules and sodium bicarbonate injection is stable for up to 14 days at 24 degrees C and up to 30 days at 5 and -20 degrees C.
DOI
Stability of Partial Doses of Omeprazole–Sodium Bicarbonate Oral Suspension
Omeprazole-sodium bicarbonate oral suspension is stable for 45 days, stable with partial doses, and easily administered through neonatal and pediatric feeding tubes, making it cost-effective compared to lansoprazole.
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use.
Omeprazole-sodium bicarbonate suspensions for pediatric use maintain high stability and viscosity, even after prolonged storage at room temperature.
DOI